Clinical Trial Update: Doxapram Therapy in Preterm Infants (DOXA Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial update for doxapram therapy in preterm infants with apnea of prematurity and respiratory insufficiency; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity
• Respiratory Insufficiency

Drugs mentioned

• Doxapram (Doxapram)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Apnea of Prematurity, Respiratory Insufficiency | Phase 3 | Status: RECRUITING